Selatogrel for heart attack patients | ‘Do-not-resuscitate’ orders for COVID-19 | A tragic loss

A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology.

New findings highlight why a blanket “do-not-resuscitate” order for COVID-19 patients is not needed. 

L. Theodore Lawrence Jr., MD, who fought in World War II and went on to treat veterans as a cardiologist, died May 5 due to COVID-19 complications.

Male cardiologists earn approximately 15% more than their female counterparts, according to a new report from Medscape. 

Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.

Rosiglitazone was once a popular treatment for Type 2 diabetes, but it fell out of favor due to a variety of side effects.

After seeing telehealth visits skyrocket 3,700% in April over March—most of them COVID-related—UPMC is touting its use of AI to help patients retain and apply doctors’ guidance offered during virtual visits.

Medical imaging volume was hit hard by the COVID-19 pandemic. Fortunately, as the old adage says, this too shall pass. But when? And what should practices being doing to prepare for the return?